Skip to main content
Clinical Trials/NCT05911932
NCT05911932
Recruiting
N/A

Investigating Genetic Status in Patients Presenting to Clinic

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dementia, Frontotemporal
Sponsor
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Enrollment
1000
Locations
1
Primary Endpoint
Blood draw for genetic status or polymorphism result.
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The causes of neurodegenerative dementias such as Frontotemporal Dementia, Lewy Body Disease and Alzheimer's disease are still largely unknown. While the contribution of some genetic mutations and polymorphisms is associated with autosomal dominant patterns of inheritance of these dementias, in many cases, the specific causative mutation in these families is not yet identified. Further, in many patients, polygenic risk is thought to give rise to pathophysiologic changes, but which specific genes affect risk are largely yet unknown. By examining genotypes in patients that present to our Cognitive Neurology and Alzheimer's Research Clinic with suspected or confirmed neurodegenerative dementia, or have a history of a familial dementia, we aim to help identify and characterize genetic mutations or polymorphisms that give rise to neurodegenerative diseases.

Registry
clinicaltrials.gov
Start Date
October 20, 2023
End Date
August 2043
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Elizabeth Finger

Associate Professor

London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's

Eligibility Criteria

Inclusion Criteria

  • Persons presenting to the cognitive clinic with a neurodegenerative disorder (for example, AD, FTD, LBD, ALSP, and related conditions);
  • Biological family members of someone diagnosed with a neurodegenerative disorder, presenting to clinic;
  • Age 18+ years old;
  • Consenting to a blood draw.

Exclusion Criteria

  • Persons declining / unwilling / not able to have a blood draw.

Outcomes

Primary Outcomes

Blood draw for genetic status or polymorphism result.

Time Frame: A one-time visit, taking the participant approximately 20 minutes total for all study procedures.

The blood draw is taken at the time of the clinic visit. Up to 30ml will be collected by standard venipuncture.

Secondary Outcomes

  • Demographic information.(A one-time visit, taking the participant approximately 20 minutes total for all study procedures.)
  • Medical history/Clinical diagnoses.(Typically within 1 month of the clinic visit, taking approximately 5 minutes.)
  • Pathological diagnoses.(Typically within 1 month of the clinic visit, taking approximately 5 minutes.)

Study Sites (1)

Loading locations...

Similar Trials